Last reviewed · How we verify

NCT03862521

Safety of Low and Very Low Carbohydrate Diets in Young Children With Type 1 Diabetes

Completed NA Last updated 25 May 2022
What this trial tests

NA trial testing Low carbohydrate diet in Type 1 Diabetes Mellitus in 16 participants. Completed in 28 February 2022.

Timeline
1 August 2018
Primary endpoint
28 February 2022
28 February 2022

Quick facts

Lead sponsorNemours Children's Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment16
Start date1 August 2018
Primary completion28 February 2022
Estimated completion28 February 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Nemours Children's Clinic

Who can join

Adults 2 to 11, any sex, with Type 1 Diabetes Mellitus or Diet Modification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the safety of short-term (6 month) low or very-low carbohydrate diets in prepubertal children 2 to \<12 years old with type 1 diabetes. Participants will be randomized to either low carbohydrate diet (carbohydrate makes up 30-39% of total daily calories) or very-low carbohydrate diet (carbohydrates are 20-29% of total daily calories). The investigators will evaluate metabolic effects of these diets by measuring the counter-regulatory hormone response to hypoglycemia at baseline and again at 3 months. Other outcomes include diabetes control as measured by HbA1c, growth and weight gain, lipid profiles, and body composition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Low carbohydrate diet

Trials testing the same drug.

Other recruiting trials for Type 1 Diabetes Mellitus

Currently open trials in the same condition.

Other Nemours Children's Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03862521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing